(NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation -- Polymorph and Stereoisomer Patents when Issued Extend ...
NMR chemical shift calculation suggested a single stereoisomer as the most likely structure, and its validation by total synthesis enabled successful elucidation of the stereostructure of ...
School of Civil, Environmental and Architectural Engineering, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea KU-KIST Graduate School of Converging Science and Technology, ...